Literature DB >> 15885626

Controversy: is Parkinson's disease a single disease entity? Yes.

H Takahashi1, K Wakabayashi.   

Abstract

Parkinson's disease (PD) is a common, and in principle, sporadic, neurodegenerative disorder that occurs in adults. Pathological studies have revealed that in PD, nerve cell loss and Lewy bodies (LB) are distributed widely in the nervous system. Moreover, molecular pathology has made remarkable advances over the last several years, after the identification of alpha-synuclein gene abnormality in familial PD. Extensive pathological findings support the idea that PD is a single disease entity and that there are no cases of PD in which neurodegeneration occurs only in the substantia nigra and in which there are no LBs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885626     DOI: 10.1016/j.parkreldis.2005.02.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.

Authors:  Caroline Santos Capitelli; Carolina Salomão Lopes; Angélica Cristina Alves; Janaína Barbiero; Lucas Felipe Oliveira; Valdo José Dias da Silva; Maria Aparecida Barbato Frazão Vital
Journal:  Int J Med Sci       Date:  2014-08-03       Impact factor: 3.738

2.  Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade.

Authors:  Hsing-Chun Kuo; Chien-Chang Lu; Chien-Heng Shen; Shui-Yi Tung; Meng Chiao Hsieh; Ko-Chao Lee; Li-Ya Lee; Chin-Chu Chen; Chih-Chuan Teng; Wen-Shih Huang; Te-Chuan Chen; Kam-Fai Lee
Journal:  J Transl Med       Date:  2016-03-18       Impact factor: 5.531

Review 3.  Parkinson's disease: a dual-hit hypothesis.

Authors:  C H Hawkes; K Del Tredici; H Braak
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-24       Impact factor: 8.090

4.  Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.

Authors:  Emanuela Esposito; Daniela Impellizzeri; Emanuela Mazzon; Irene Paterniti; Salvatore Cuzzocrea
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

5.  A Mouse Model of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Parkinson Disease Shows that 2-Aminoquinoline Targets JNK Phosphorylation.

Authors:  Meie Zhu; Daokai Gong
Journal:  Med Sci Monit       Date:  2020-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.